CT Severity Score in COVID-19
The CT severity score (CT-SS) is a semi-quantitative scoring system that divides each lung into 20 regions, assigning each region a score of 0 (no involvement), 1 (<50% involvement), or 2 (≥50% involvement), yielding a total possible score of 0-40 points. 1
How the Score is Calculated
The scoring system evaluates lung parenchymal opacification across 20 anatomical segments:
- Each of the 5 lobes is divided into 4 regions
- Score 0: No parenchymal involvement
- Score 1: Less than 50% of the region shows ground-glass opacities or consolidation
- Score 2: 50% or more of the region is involved
- Total score ranges from 0 to 40 1, 2
Clinical Interpretation and Severity Thresholds
A CT severity score of ≥19.5 is the validated threshold for identifying severe COVID-19 disease, with 83-84% sensitivity and 92-94% specificity 1, 3, 2. This cutoff effectively discriminates between mild and severe clinical presentations.
Alternative Scoring Systems
While multiple CT scoring systems exist (ranging from CT-SS 5 to CT-SS 30), the CT-SS 30 system demonstrated the highest diagnostic accuracy (AUC = 0.805) in a 2024 validation study 4. However, the traditional 0-40 point system remains most widely used and validated across multiple studies.
Correlation with Clinical Parameters
The CT severity score shows moderate to strong correlations with key clinical and laboratory markers:
- Strongest correlation: LDH (ρ = 0.68) 5
- Negative correlations: SpO2, lymphocyte percentage, serum albumin 5, 6
- Positive correlations: CRP, ferritin, fibrinogen, D-dimer, neutrophil percentage 5, 6
In multivariable analysis, LDH, glucose, creatinine, and lymphocyte percentage independently predict CT severity score, explaining approximately 40% of its variance 5.
Anatomical Distribution Patterns
The lower lobes are most frequently and severely involved, particularly:
- Posterior basal segments (left: 81/102; right: 83/102 cases)
- Superior segments of lower lobes
- Lateral basal segments 1, 3
The posterior segments of upper lobes are also commonly affected, but lower lobe involvement shows the strongest correlation with disease severity 1, 5.
Clinical Application Context
When CT Scoring is Appropriate
Based on Fleischner Society guidelines 7, 8:
- Indicated: Patients with moderate-severe clinical features and worsening respiratory status
- Indicated: Resource-constrained settings for medical triage when RT-PCR unavailable or negative
- NOT indicated: Mild cases without risk factors for progression
- NOT indicated: Routine screening in asymptomatic individuals
Prognostic Value
Each 1-point increase in CT severity score is associated with a 1.048-fold increase in mortality risk 9. A score of ≥25.5 predicts mortality with 75% sensitivity and 85.7% specificity (AUC = 0.857) 9.
Important Caveats
- Predominance of consolidations or mixed consolidation/ground-glass opacities predicts more severe disease, while ground-glass opacities alone do not 4
- CT findings are nonspecific and must be interpreted within clinical context
- Daily chest radiographs are NOT indicated in stable intubated COVID-19 patients 7, 8
- Interobserver agreement for CT severity scoring is excellent (ICC: 0.982-0.995) 4, making it reproducible across radiologists